Mayo Clinic Forefront: Novel drug may benefit myelofibrosis patients

Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Post Reply
Fishermangents
Site Admin
Posts: 531
Joined: Thu Dec 03, 2015 3:39 pm

Mayo Clinic Forefront: Novel drug may benefit myelofibrosis patients

Post by Fishermangents » Tue Jan 19, 2016 10:17 pm

(not new, but nice anyway...)

Forefront, Mayo Clinic, Volume 4, issue 4, 2015

Researchers in the Mayo Clinic Cancer Center are studying a novel drug called imetelstat for the treatment of patients with myelofibrosis. Results of a Mayo Clinic study of the drug were published in the New England Journal of Medicine in September 2015.
"We observed that imetelstat was active and induced morphologic and molecular remissions in some patients with myelofibrosis," said Ayalew Tefferi, M.D., a hematologist in the Mayo Clinic Cancer Center and lead author of the published study. "We also observed that imetelstat demonstrated selective anticlonal activity, inhibiting the growth of cancer cells, which we had not previously documented with other drugs."

full article: http://www.mayo.edu/research/forefront/ ... s-patients

Post Reply